JP2019504108A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019504108A5 JP2019504108A5 JP2018544438A JP2018544438A JP2019504108A5 JP 2019504108 A5 JP2019504108 A5 JP 2019504108A5 JP 2018544438 A JP2018544438 A JP 2018544438A JP 2018544438 A JP2018544438 A JP 2018544438A JP 2019504108 A5 JP2019504108 A5 JP 2019504108A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- methyl
- benzo
- diazepine
- cyclopropane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15194611 | 2015-11-13 | ||
| EP15194611.8 | 2015-11-13 | ||
| PCT/GB2016/053550 WO2017081483A1 (en) | 2015-11-13 | 2016-11-11 | Substituted tricyclic 1,4-benzodiazepinone derivatives as allosteric modulators of group ii metabotropic glutamate receptors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019504108A JP2019504108A (ja) | 2019-02-14 |
| JP2019504108A5 true JP2019504108A5 (enExample) | 2019-12-19 |
| JP7100362B2 JP7100362B2 (ja) | 2022-07-13 |
Family
ID=54542126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018544438A Expired - Fee Related JP7100362B2 (ja) | 2015-11-13 | 2016-11-11 | グループｉｉ代謝型グルタミン酸受容体のアロステリックモジュレーターとしての置換三環式１，４－ベンゾジアゼピノン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US11008323B2 (enExample) |
| EP (1) | EP3374360A1 (enExample) |
| JP (1) | JP7100362B2 (enExample) |
| KR (1) | KR20180097542A (enExample) |
| CN (1) | CN108834415B (enExample) |
| AU (1) | AU2016354661B2 (enExample) |
| BR (1) | BR112018009550A2 (enExample) |
| CA (1) | CA3004680A1 (enExample) |
| IL (1) | IL259214B (enExample) |
| WO (1) | WO2017081483A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110769830A (zh) * | 2017-05-12 | 2020-02-07 | 马瓦隆治疗有限公司 | 作为ii组代谢型谷氨酸受体的别构调节剂的取代的杂环化合物 |
| CN108084187A (zh) * | 2017-12-15 | 2018-05-29 | 宜昌人福药业有限责任公司 | 苯并二氮杂*类氢化物 |
| CN108003164A (zh) * | 2017-12-15 | 2018-05-08 | 宜昌人福药业有限责任公司 | 苯并二氮杂*类化合物 |
| WO2020223701A1 (en) * | 2019-05-02 | 2020-11-05 | The Broad Institute, Inc. | Methods for treating neurodevelopmental disorders |
| CN110172068A (zh) * | 2019-06-05 | 2019-08-27 | 河南龙湖生物技术有限公司 | 具有抗肿瘤活性的苯并噻唑类化合物及其制备方法和应用 |
| WO2021226208A2 (en) | 2020-05-05 | 2021-11-11 | Nuvalent, Inc. | Heteroaromatic macrocyclic ether chemotherapeutic agents |
| KR102698413B1 (ko) | 2020-05-05 | 2024-08-26 | 뉴베일런트, 아이엔씨. | 헤테로방향족 거대환식 에터 화학치료제 |
| TW202320768A (zh) | 2021-10-01 | 2023-06-01 | 美商努法倫特公司 | 雜芳族大環醚化合物之固體形式、醫藥組成物及製備 |
| WO2026006700A1 (en) * | 2024-06-28 | 2026-01-02 | Regents Of The University Of Michigan | Pyrrolo[1,2-a]-azocine analogues as iap antagonists |
| CN118993997A (zh) * | 2024-10-23 | 2024-11-22 | 浙江雅辰药物科技股份有限公司 | 一种3-溴-2-苯基吡啶的制备方法 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
| US4130716A (en) | 1977-03-07 | 1978-12-19 | Hoffmann-La Roche Inc. | Pyrazolo benzodiazepines |
| US4263428A (en) | 1978-03-24 | 1981-04-21 | The Regents Of The University Of California | Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same |
| DE3169595D1 (en) | 1980-11-10 | 1985-05-02 | Gersonde Klaus | Method of preparing lipid vesicles by ultrasonic treatment, the use of this method and apparatus for its application |
| US4485045A (en) | 1981-07-06 | 1984-11-27 | Research Corporation | Synthetic phosphatidyl cholines useful in forming liposomes |
| EP0088046B1 (de) | 1982-02-17 | 1987-12-09 | Ciba-Geigy Ag | Lipide in wässriger Phase |
| DE3218121A1 (de) | 1982-05-14 | 1983-11-17 | Leskovar, Peter, Dr.-Ing., 8000 München | Arzneimittel zur tumorbehandlung |
| EP0102324A3 (de) | 1982-07-29 | 1984-11-07 | Ciba-Geigy Ag | Lipide und Tenside in wässriger Phase |
| US4544545A (en) | 1983-06-20 | 1985-10-01 | Trustees University Of Massachusetts | Liposomes containing modified cholesterol for organ targeting |
| HUT35524A (en) | 1983-08-02 | 1985-07-29 | Hoechst Ag | Process for preparing pharmaceutical compositions containing regulatory /regulative/ peptides providing for the retarded release of the active substance |
| DE3486459D1 (de) | 1983-09-26 | 1997-12-11 | Udo Dr Med Ehrenfeld | Mittel und Erzeugnis für die Diagnose und Therapie von Tumoren sowie zur Behandlung von Schwächen der zelligen und humoralen Immunabwehr |
| EP0143949B1 (en) | 1983-11-01 | 1988-10-12 | TERUMO KABUSHIKI KAISHA trading as TERUMO CORPORATION | Pharmaceutical composition containing urokinase |
| FI880814A7 (fi) | 1987-03-10 | 1988-09-11 | Hoffmann La Roche | Imidazodiazepin-derivat. |
| MX2009007053A (es) | 2006-12-28 | 2009-07-09 | Abbott Lab | Inhibidores de poli (adp-ribosa) polimerasa. |
| US10059671B2 (en) | 2013-02-04 | 2018-08-28 | Prexton Therapeutics Sa | Positive allosteric modulators of mGluR3 |
-
2016
- 2016-11-11 CA CA3004680A patent/CA3004680A1/en not_active Abandoned
- 2016-11-11 AU AU2016354661A patent/AU2016354661B2/en not_active Ceased
- 2016-11-11 JP JP2018544438A patent/JP7100362B2/ja not_active Expired - Fee Related
- 2016-11-11 EP EP16797625.7A patent/EP3374360A1/en not_active Withdrawn
- 2016-11-11 KR KR1020187016380A patent/KR20180097542A/ko not_active Ceased
- 2016-11-11 CN CN201680078195.9A patent/CN108834415B/zh not_active Expired - Fee Related
- 2016-11-11 WO PCT/GB2016/053550 patent/WO2017081483A1/en not_active Ceased
- 2016-11-11 BR BR112018009550A patent/BR112018009550A2/pt not_active Application Discontinuation
- 2016-11-11 US US15/775,725 patent/US11008323B2/en not_active Expired - Fee Related
-
2018
- 2018-05-08 IL IL259214A patent/IL259214B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6669745B2 (ja) | ブロモドメインのインヒビターとしての置換ピロロピリジン | |
| US12291535B2 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| JP6669744B2 (ja) | ブロモドメインのインヒビターとしての置換ピロロピリジン | |
| JP6847844B2 (ja) | 治療用ピリダジン化合物およびその使用 | |
| EP2963037B1 (en) | Novel pyrazole derivative | |
| AU2018346712B2 (en) | P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD | |
| JP2019516757A (ja) | Ｃｂｐ／ｅｐ３００の複素環式インヒビターおよびがんの処置におけるそれらの使用 | |
| AU2007325403A1 (en) | Methods of treating cognitive impairment and dementia | |
| US12528819B2 (en) | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | |
| JP2024056755A5 (enExample) | ||
| JP2019516759A (ja) | がんの処置のためのピラゾロピリジン誘導体 | |
| JP2001097889A (ja) | Ｃｒｆアンタゴニストおよび関連組成物の使用 | |
| US20060258691A1 (en) | Methods and compositions for improving cognition | |
| JP2014517050A5 (enExample) | ||
| JP2016537384A5 (enExample) | ||
| JP2013545779A5 (enExample) | ||
| JP2011529504A5 (enExample) | ||
| JP2021054843A (ja) | トロポミオシン関連キナーゼ（ｔｒｋ）阻害剤 | |
| JP2014513139A5 (enExample) | ||
| JP2012526736A5 (enExample) | ||
| JP2014503544A5 (enExample) | ||
| RU2020124136A (ru) | Производные хроменопиридина в качестве ингибиторов фосфатидилинозитолфосфаткиназы | |
| TR201907981T4 (tr) | Heteroaromatik bileşikler ve bunların dopamin d1 ligandları olarak kullanımı. | |
| JP2020526549A5 (enExample) | ||
| Makaron et al. | Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys |